Gyre Therapeutics (GYRE) Other financing activities (2010 - 2025)
Gyre Therapeutics (GYRE) reported Other financing activities of -$315000.0 for Q3 2025, down 730.0% year-over-year from $50000.0 in Q3 2024, and down 118.74% on a QoQ basis from $1.7 million in Q2 2025.
Gyre Therapeutics (GYRE) has 7 years of Other financing activities data on file, last reported at -$315000.0 in Q3 2025.
- Quarterly Other financing activities fell 730.0% year-over-year to -$315000.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $1.5 million (up 34.94% YoY) and the FY2025 annual result came in at $1.5 million, up 177.43% from the prior year.
- Other financing activities retreated to -$315000.0 in Q3 2025 per GYRE's latest filing, from $1.7 million in the prior quarter.
- Across five years, Other financing activities topped out at $1.7 million in Q2 2025 and bottomed at -$315000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -315,000.00 |
| Sep 30, 2025 | -315,000.00 |
| Jun 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Mar 31, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 367,000.00 |
| Dec 31, 2024 | 367,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Sep 30, 2024 | 50,000.00 |
| Dec 31, 2017 | 403,000.00 |
| Dec 31, 2017 | 403,000.00 |
| Sep 30, 2017 | 282,000.00 |
| Sep 30, 2017 | 282,000.00 |
| Jun 30, 2017 | 6.88 Mn |
| Jun 30, 2017 | 6.88 Mn |
| Mar 31, 2017 | 6.75 Mn |
| Mar 31, 2017 | 6.75 Mn |
| Dec 31, 2016 | 10.26 Mn |
| Dec 31, 2016 | 10.26 Mn |
| Sep 30, 2016 | 676,000.00 |
| Sep 30, 2016 | 676,000.00 |
| Jun 30, 2016 | 592,000.00 |
| Jun 30, 2016 | 592,000.00 |
| Mar 31, 2016 | 2.81 Mn |
| Mar 31, 2016 | 2.81 Mn |
| Dec 31, 2015 | 1.03 Mn |
| Dec 31, 2015 | 1.03 Mn |
| Mar 31, 2014 | 3.41 Mn |
| Mar 31, 2014 | 3.41 Mn |
| Dec 31, 2010 | 1.23 Mn |
| Dec 31, 2010 | 1.23 Mn |
| Sep 30, 2010 | 160,000.00 |
| Sep 30, 2010 | 160,000.00 |